Health Care · Pharmaceutical Preparations · Nasdaq · CIK 2023311 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $18.31Day +0.14%1Y −54.3%Off 52W high −62.2%Vol (1Y) 61.7%
Daily closing price, split-adjusted to the current basis; 1.5y shown of 368 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover2.2d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)CNY 980.6M |
| Earnings (TTM)-CNY 405.4M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CNY). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−30.2% |
| 1Y−54.3% |
| Since incept. (ann.)+4.1% |
Total return through 2026-07-29 · series begins 2025-01-27. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)61.7% |
| Ann. volatility (3Y)64.1% |
| Sharpe (1Y)−0.98 |
| Sharpe (3Y)0.38 |
| Max drawdown (1Y)−65.0% |
| Max drawdown (3Y)−65.0% |
| Beta (3Y vs SPY)0.16 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 16,056 | $383,257 | 0.00% | −4.0% |
| XY Capital Ltd | 13,014 | $310,644 | 0.00% | −4.5% |
| Tower Research Capital LLC (TRC) | 518 | $12,365 | 0.00% | +125.2% |
| MORGAN STANLEY | 498 | $11,887 | 0.00% | +225.5% |
| UBS Group AG | 124 | $2,960 | 0.00% | −97.1% |
| EverSource Wealth Advisors, LLC | 24 | $573 | 0.00% | +0.0% |
| ROYAL BANK OF CANADA | 6 | $0 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for AAPG.
